AlphaFold predicted structure
MMP2 · P08253

Mean pLDDT
89.8/ 100
Confident
660 residues
Confidence breakdown
- Very high(≥ 90)77%
- Confident(70–90)15%
- Low(50–70)2%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
matrix metallopeptidase 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Skeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalOsteogenesis imperfecta
Torg-Winchester syndrome
multicentric osteolysis-nodulosis-arthropathy spectrum
Nodulosis-arthropathy-osteolysis syndrome
non-small cell lung carcinoma
lip and oral cavity carcinoma
fibroblastic disorder
chromosome 16q12 duplication syndrome
breast cancer
musculoskeletal system disorder
prostate cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
72 kDa type IV collagenase
Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14
MMP2 · P08253

Mean pLDDT
89.8/ 100
Confident
660 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0